Optimization of Pharmacokinetics Through Manipulation of Physicochemical Properties in a Series of HCV Inhibitors.
Scott E. Lazerwith,Gina Bahador,Eda Canales,Guofeng Cheng,Lee Chong,Michael O. Clarke,Edward Doerffler,Eugene J. Eisenberg,Jaclyn Hayes,Bing Lu,Qi Liu,Mike Matles,Michael Mertzman,Michael L. Mitchell,Philip Morganelli,Bernard P. Murray,Margaret Robinson,Robert G. Strickley,Megan Tessler,Neeraj Tirunagari,Jianhong Wang,Yujin Wang,Jennifer R. Zhang,Xubin Zheng,Weidong Zhong,William J. Watkins ACS Medicinal Chemistry Letters（2011）
关键词
Pharmacokinetics,HCV inhibitors,pyrido[3,2-d]pyrimidine core,3*HBD-cLogP
AI 理解论文
溯源树
样例
